Accuray Incorporated (ARAY) Estados Financieros e Histórico

Accuray Incorporated (ARAY) — Precio $0.24 HealthcareMedical - Devices — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Accuray Incorporated (ARAY): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Accuray Incorporated registró ingresos de $401.9M en el último ejercicio fiscal, con un CAGR de 5 años del 0.3%.

Márgenes de los últimos 12 meses: margen bruto 27.7%, margen operativo -6.6%, margen neto -12.2%.

Al precio actual de $0.24, ARAY presenta beneficios negativos (P/E no significativo) y un ROE del -99.04%. La capitalización bursátil es de $29M.

Cuenta de Resultados (10 años)

Año2017201820192020202120222023202420252026
Ingresos$383.4M$404.9M$418.8M$382.9M$396.3M$429.9M$447.6M$446.6M$458.5M$401.9M
Coste de Ventas$242.1M$243.2M$256.1M$233.2M$236.8M$270.0M$293.6M$303.6M$311.5M$290.5M
Beneficio Bruto$141.3M$161.7M$162.7M$149.7M$159.5M$160.0M$154.0M$142.9M$147.0M$111.5M
I+D$49.9M$57.3M$56.5M$49.8M$52.7M$57.8M$57.1M$49.7M$47.9M$37.8M
Generales y Administrativos$101.2M$108.2M$105.6M$87.4M$84.5M$94.1M$94.4M$92.7M$91.2M$84.0M
Gastos Operativos$151.2M$165.5M$162.1M$137.2M$137.3M$151.8M$151.6M$142.4M$139.1M$137.9M
Beneficio Operativo-$9.8M-$3.8M-$9.9M$12.5M$22.2M$8.1M$2.4M$504000$7.8M-$26.4M
EBITDA$6.8M$1.7M$11.1M$31.3M$18.7M$11.6M$8.4M$5.7M$20.2M-$14.3M
Gastos por Intereses$17.3M$15.0M$15.1M$18.1M$16.9M$8.1M$10.6M$11.6M$13.0M$35.3M
Beneficio Antes de Impuestos-$28.5M-$23.0M-$14.3M$5.7M-$4.6M-$2.0M-$6.8M-$11.8M$1.1M-$47.2M
Impuestos$1.0M$878000$2.1M$1.9M$1.8M$3.3M$2.5M$3.7M$2.7M$1.9M
Beneficio Neto-$29.6M-$23.9M-$16.4M$3.8M-$6.3M-$5.3M-$9.3M-$15.5M-$1.6M-$49.2M
BPA$-0.36$-0.28$-0.19$0.04$-0.07$-0.06$-0.10$-0.16$-0.02$-0.40
BPA Diluido$-0.36$-0.28$-0.19$0.04$-0.07$-0.06$-0.10$-0.16$-0.02$-0.40
Acciones en Circulación (Diluidas)$82.5M$84.9M$87.5M$90.6M$92.0M$92.1M$94.9M$98.3M$102.8M$122.6M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$93.9M$102.2M$104.8M$100.9M
Beneficio Bruto$26.5M$24.1M$25.3M$35.5M
Beneficio Operativo-$11.3M-$5.5M-$2.5M-$7.1M
EBITDA-$10.3M-$3.3M-$813000$71000
Beneficio Neto-$21.7M-$13.8M-$11.8M-$1.9M
BPA$-0.18$-0.11$-0.09$-0.02
BPA Diluido$-0.18$-0.11$-0.09$-0.02

Balance (10 años)

Año2017201820192020202120222023202420252026
Caja y Equivalentes$72.1M$83.1M$76.8M$107.6M$116.4M$88.7M$89.4M$68.6M$57.4M$41.2M
Inversiones a Corto$23.9M000000000
Cuentas por Cobrar$72.8M$66.0M$111.9M$90.6M$85.4M$101.5M$87.3M$98.9M$97.9M$67.4M
Inventario$105.1M$108.5M$120.8M$134.4M$125.9M$142.3M$145.2M$138.3M$141.0M$147.1M
Activos Corrientes$309.0M$284.2M$344.1M$357.5M$352.8M$350.9M$338.0M$323.2M$317.5M$287.5M
Inmovilizado Material$23.1M$23.7M$17.1M$44.0M$34.9M$29.5M$46.8M$58.5M$61.8M$54.8M
Fondo de Comercio$57.8M$57.9M$57.8M$57.7M$58.0M$57.8M$57.7M$57.7M$57.8M$57.9M
Activos Intangibles$964000$821000$679000$663000$435000$250000$210000$59000$150000
Activos Totales$406.5M$378.7M$438.2M$490.9M$480.1M$472.8M$479.2M$468.6M$470.2M$443.7M
Cuentas por Pagar$17.5M$19.7M$29.6M$23.1M$19.5M$31.3M$33.7M$50.0M$34.0M$40.6M
Deuda a Corto$113.0M000$3.8M$8.6M$5.7M$7.8M$12.7M$9.7M
Pasivos Corrientes$284.5M$169.4M$192.2M$182.3M$192.4M$208.9M$198.6M$195.3M$192.6M$191.4M
Deuda a Largo$51.5M$131.1M$159.8M$189.3M$170.0M$171.9M$171.6M$164.4M$123.8M$146.4M
Pasivos Totales$359.9M$330.1M$388.3M$427.3M$411.3M$419.7M$425.6M$423.5M$389.1M$402.0M
Reservas-$450.4M-$474.3M-$485.5M-$481.7M-$488.0M-$492.5M-$502.1M-$517.7M-$519.3M-$568.5M
Patrimonio Neto$46.5M$48.6M$49.9M$63.6M$68.8M$53.2M$53.7M$45.1M$81.2M$41.7M
Deuda Total$164.6M$131.1M$159.8M$221.7M$199.4M$199.5M$205.0M$210.7M$176.4M$183.9M
Deuda Neta$68.6M$48.0M$83.0M$114.1M$83.0M$110.8M$115.6M$142.2M$119.0M$142.6M
Capital Circulante$24.5M$114.7M$151.9M$175.2M$160.4M$142.0M$139.4M$128.0M$124.9M$96.1M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$63.9M$41.3M$38.1M$40.6M
Activos Totales$456.8M$448.0M$447.6M$443.7M
Pasivos Totales$394.9M$394.6M$405.9M$402.0M
Patrimonio Neto$61.9M$53.4M$41.7M$41.7M
Deuda Total$179.1M$204.4M$182.4M$183.9M

Flujo de Caja (10 años)

Año2017201820192020202120222023202420252026
Beneficio Neto-$29.6M-$23.9M-$16.4M$3.8M-$6.3M-$5.3M-$9.3M-$15.5M-$1.6M-$49.2M
Amortizaciones$18.0M$9.7M$10.5M$7.5M$6.4M$5.5M$4.5M$5.9M$6.2M$7.9M
Compensación en Acciones$13.6M$12.3M$10.6M$8.2M$9.3M$10.6M$10.1M$9.5M$10.2M$6.5M
Cambio en Capital Circulante-$12.5M$10.0M-$46.7M-$21.9M$7.8M-$22.6M$4.6M-$21.9M-$18.2M$11.9M
Flujo de Caja Operativo-$380000$18.3M-$29.6M-$1.5M$38.5M-$2.4M$15.5M-$11.9M$2.9M-$7.0M
Inversiones (CapEx)-$5.4M-$6.6M-$4.3M-$3.7M-$2.3M-$4.7M-$12.7M-$3.6M-$8.5M-$5.9M
Adquisiciones$333000$33300000-$7900000000
Recompra de Acciones-$1.4M-$29300000-$14.1M00000
Dividendos Pagados0000000000
Flujo de Caja Libre-$5.7M$11.7M-$34.0M-$5.2M$36.2M-$7.1M$2.9M-$15.5M-$5.7M-$12.8M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo$12.2M-$16.0M-$5.6M$2.4M
Inversiones (CapEx)-$3.8M-$1.1M-$1.5M-$461000
Flujo de Caja Libre$8.4M-$17.1M-$7.1M$2.0M
Dividendos Pagados0000
Compensación en Acciones$2.5M$882000$1.4M$1.7M

Crecimiento y Márgenes (10 años)

Año2017201820192020202120222023202420252026
Crecimiento Ingresos (anual)+5.6%+3.4%-8.6%+3.5%+8.5%+4.1%-0.2%+2.7%-12.3%
Crecimiento Beneficio Neto (anual)+19.2%+31.3%+123.3%-264.9%+15.3%-73.6%-67.5%+89.8%-2992.0%
Crecimiento BPA (anual)+22.2%+32.1%+122.4%-261.0%+15.3%-68.3%-63.6%+90.3%-2480.6%
Cambio en Acciones (anual)+2.9%+3.0%+3.6%+1.6%+0.1%+3.0%+3.6%+4.6%+19.3%
Crecimiento FCF (anual)+304.1%-389.6%+84.7%+796.4%-119.7%+140.2%-642.5%+63.5%-126.8%
Margen Bruto36.9%39.9%38.8%39.1%40.3%37.2%34.4%32.0%32.1%27.7%
Margen Operativo-2.6%-0.9%-2.4%3.3%5.6%1.9%0.5%0.1%1.7%-6.6%
Margen EBITDA1.8%0.4%2.6%8.2%4.7%2.7%1.9%1.3%4.4%-3.6%
Margen Neto-7.7%-5.9%-3.9%1.0%-1.6%-1.2%-2.1%-3.5%-0.3%-12.2%
Margen FCF-1.5%2.9%-8.1%-1.4%9.1%-1.7%0.6%-3.5%-1.2%-3.2%
Tasa Impositiva Efectiva-3.6%-3.8%-14.5%32.7%-38.4%-167.1%-36.7%-31.5%240.3%-4.1%

Datos por Acción (10 años)

Año2017201820192020202120222023202420252026
FCF por Acción$-0.07$0.14$-0.39$-0.06$0.39$-0.08$0.03$-0.16$-0.06$-0.10
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$82.5M$84.9M$87.5M$89.9M$92.0M$92.1M$94.9M$98.3M$102.8M$122.6M

Qué mirar en Salud / Farma

El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.

Rentabilidad

Rentabilidad sobre capital-99.04%
Rentabilidad sobre capital invertido-10.09%
Rentabilidad sobre activos-11.09%
Margen bruto27.73%
Margen operativo-6.58%
Margen neto-12.24%

Salud financiera

Deuda / Patrimonio4.41
Ratio corriente1.50

Ratios Clave (10 años)

Año2017201820192020202120222023202420252026
P/E-13.19-14.64-20.5847.65-65.89-33.73-39.57-11.00-88.39-0.64
P/VC8.427.166.862.876.043.396.843.841.730.76
P/V1.020.860.820.481.050.420.820.390.310.08
Margen Bruto36.9%39.9%38.8%39.1%40.3%37.2%34.4%32.0%32.1%27.7%
Margen Operativo-2.6%-0.9%-2.4%3.3%5.6%1.9%0.5%0.1%1.7%-6.6%
Margen Neto-7.7%-5.9%-3.9%1.0%-1.6%-1.2%-2.1%-3.5%-0.3%-12.2%

Empresas relacionadas: ANIK · AVR · LNSR · MIST · MXCT · OWLT · PROF

Explorar sector: Healthcare · Medical - Devices

Más secciones de ARAY: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones